SEARCH

SEARCH BY CITATION

REFERENCES

  • Boden V, Rangeard MH, Mrabet N, Vijayalakshmi MA. 1998. Histidine mapping of serine proteases: a synergic study by IMAC and molecular modeling. J. Mol. Recognit. 11: 3239.
  • Brne P, Podgorink A, Bencina K, Gabor B, Strancar A, Peterka M. 2007. Fast and efficient separation of immunoglobulin M from immunoglobulin G using short monolithic columns. J. Chromatogr. A. 1144: 120125.
  • Corey DR, Crail CS. 1992. An investigation into the minimum requirements for peptide hydrolysis by mutation of the catalytic triad of trypsin. J.Am. Chem. Soc. 114: 49054907.
  • Corper AL, Sohi MK, Bonagura VR, Steintiz M, Jefferis R, Feinstein A, Beale D, Taussig MJ, Sutton BJ. 1997. Structure of human IgM rheumatoid factor Fab bound to its autoantigen IgG Fc reveals a novel topology of antibody-antigen interaction. Nat. Struct. Biol. 4: 374381.
  • Dodson G, Wlodawer A. 1998. Catalytic triads and their relatives. Trend. Biochem. Sci. 23: 347352.
  • Edwards JC, Cambridge G. 1998. Rheumatoid arthritis: the predictable effect of small immune complexes in which antibody is also antigen. Br. J. Rheumatol. 37: 126130.
  • Gabibov AG, Ponomarenko NA, Tretyak EB, Paltsev MA, Suchkov SV. 2006. Catalytic autoantibodies in clinical autoimmunity and modern medicine. Autoimmun. Rev. 5: 324330.
  • Kamalanathan AS, Vijayalakshmi MA. 2009. Molecular studies of rheumatoid factor using pseudo bioaffinity membrane chromatography. J. Mol. Recognit. 22: 146153.
  • Karlstrom A, Zhong G, Rader C, Larsen NA, Heine A, Fuller R, List B, Tanaka F, Wilson IA, Barbas CF III, Lerner RA. 2000. Using antibody catalysis to study the outcome of multiple evolutionary trials of a chemical task. Proc. Natl. Acad. Sci. USA 97: 38783883.
  • Kolesnikov AV, Kozyr AV, Alexandrova ES, Koralewski F, Demin AV, Titov MI, Avalle B, Tramontano A, Paul S, Thomas D, Gabibov AG, Friboulet A. 2000. Enzyme mimicry by the antiidiotypic antibody approach. Proc. Natl. Acad. Sci. USA 97: 1352613531.
  • Marcelletti JF, Nakamura RM. 2003. Assessment of serological markers associated with rheumatoid arthritis: diagnostic autoantibodies and conventional disease activity markers. Clin. Appl. Immun. Rev. 4: 109123.
  • Nevinsky GA, Kanyshkova TG, Buneva VN. 2000. Natural catalytic antibodies (abzymes) in normalcy and pathology. Biochemistry (Mosc) 65: 12451255.
  • Paetzel M, Dalbey RE. 1997. Catalytic hydroxyl/amine dyads within serine proteases. Trend. Biochem. Sci. 22: 2831.
  • Paul S, Karle S, Planque S, Taguchi H, Salas M, Nishiyama Y, Handy B, Hunter R, Edmundson AB, Hanson C. 2004. Naturally occurring proteolytic antibodies: selective IgM- catalyzed hydrolysis HIV gp120. J. Biol. Chem. 279: 3961139619.
  • Paul S, Nishiyama Y, Planque S, Taguchi H. 2006. Theory of proteolytic antibody occurrence. Immunol. Lett. 103: 816.
  • Planque S, Bangale Y, Song XT, Karle S, Taguchi H, Poindexter B, Bick R, Edmundson AB, Nishiyama Y, Paul S. 2004. Ontogeny of proteolytic immunity: IgM serine proteases. J. Biol. Chem. 279: 1402414032.
  • Podgornik A, Strancar A. 2005. Convective Interaction Media (CIM) – short layer chromatographic stationary phases. Biotechnol. Annu. Rev. 11: 281333.
  • Ramsland PA, Terzyan SS, Cloud G, Bourne CR, Farrugia W, Tribbick G, Geysen HM, Moomaw CR, Slaughter CA, Edmundson AB. 2006. Crystal structure of a glycosylated Fab from an IgM cryoglobulin with properties of a natural proteolytic antibody. Biochem. J. 395: 473481.
  • Randen I, Brown D, Thompson KM, Hughes-Jones N, Pascual V, Victor K, Capra JD, Forre O, Natvig JB. 1992. Clonally related IgM rheumatoid factors undergo affinity maturation in the rheumatoid synovial tissue. J. Immunol. 148: 32963301.
  • Sarath G, Zeece MG, Penheiter AR. 2001. Proteases assay methods. In Proteolytic Enzymes: A Practical approach, BeynonRJ, BondJS (eds). Oxford University Press: UK; 5962.
  • Sasso EH, Barber CV, Nardella FA, Yount WJ, Mannik M. 1988. Antigenic specificities of human monoclonal and polyclonal Rheumatoid factors. J. Immunol. 140: 30983107.
  • Soltys AJ, Axford JS, Sutton BJ. 1997. Rheumatoid factor: where are we now? Ann. Rheum. Dis. 56: 285286.
  • Steiner G, Smolen J. 2002. Autoantibodies in rheumatoid arthritis and their clinical significance. Arthritis Res. 4: S1S5.
  • Tornøe I, Titlestad IL, Kejling K, Erb K, Ditzel HJ, Jensenius JC. 1997. Pilot scale purification of human monoclonal IgM (COU-1) for clinical trials. J. Immunol. Methods 205: 1117.
  • Tramontano A, Gololobov G, Paul S. 2000. Proteolytic antibodies: origins, selection and induction. Chem. Immunol. 77: 117.
  • van Esch WJ, Reparon-Schuijt CC, Hamstra HJ, van Kooten C, Logtenberg T, Breedveld FC, Verweij CL. 2002. Polyreactivity of human IgG Fc-binding phage antibodies constructed from synovial fluid CD 38+B cells of patients with rheumatoid arthritis. J. Autoimmun. 19: 241250.
  • Westwood OM, Nelson PN, Hay FC. 2006. Rheumatoid factors: what's new? Rheumatology (Oxford) 45: 379385.